If a patient presents with an ophthalmological complication while receiving IFN therapy, the general recommendation is to stop IFN treatment. However, some authors suggest discontinuing treatment only in those with severe retinopathy or those with preexisting diseases like diabetes mellitus. A good outcome occurs in many cases after stopping IFN.